Search results
Averbach [24], Low [25] and Smith-McCune [26] et al increased risk of HIV acquisition associated with infection with any HPV genotype compared to no HPV infection in women. The point estimate from all three were consistent with a harmful effect of HPV infection (aHR=1.71, aHR=2.40 and aHR=2.26 respectively) although the association was only ...
- HPV and the Risk of HIV Acquisition in Women - PMC - PubMed Central (PMC)
The ability of HPV to establish a chronic infection within...
- HPV and the Risk of HIV Acquisition in Women - PMC - PubMed Central (PMC)
5 cze 2018 · The main associations of interest were the relative risk (RR) of acquiring a new HPV infection or clearing an existing HPV infection (outcomes) by HIV serostatus (exposure) (review 1), and the RR of acquiring HIV infection (outcome) by HPV status (either prevalent, recent/incident or recently cleared HPV infection) (exposure) (review 2).
HIV-related immunodeficiency has complex effects on female genital HPV, which include increased risks of infection, multiple types, persistence, reactivation and the risk to develop pre-invasive and invasive disease.
1 lut 2018 · HIV-related immunodeficiency has complex effects on female genital HPV, which include increased risks of infection, multiple types, persistence, reactivation and the risk to develop pre-invasive and invasive disease.
These results provide evidence for synergistic HIV and HPV interactions of clinical and public health relevance. HPV vaccination may directly benefit PLHIV, and help control both HPV and HIV at the population level in high prevalence settings.
The ability of HPV to establish a chronic infection within the genital mucosal epithelium has implications on HIV acquisition risk and prevention strategies, and remains an area of active research, in particular with novel therapeutic vaccines reaching trial stages in 2021 (Ayesha et al., 2021).
We conducted a systematic review and meta-analysis to synthesize the literature on HPV natural history in HIV-positive women. Specifically, we evaluate the risk of HPV incidence, persistence, and progression to cervical lesions and cancer among HIV-positive women compare to HIV-negative women.
